Biogen Reports Q2 Earnings Beat, Raises Guidance

Biogen BIIB reported second-quarter earnings of $9.15 per share, which beat the analyst consensus estimate of $7.53 by 21.51%. This is a 57.76% increase over earnings of $5.8 per share from the same period last year.

The company reported quarterly sales of $3.617 billion, which beat the analyst consensus estimate of $3.48 billion by 3.94%. This is a 7.75% increase over sales of $3.357 billion the same period last year.

Biogen also raised 2019 guidance from $28-$29 to $31.50-$32.30 versus a $29.70 estimate.

Biogen shares were trading up 1.59% at $236.17 in Tuesday’s pre-market session. The stock has a 52-week high of $388.67 and a 52-week low of $216.12.

Related Links:

Harley-Davidson Reports Mixed Q2 Earnings

Stanley Black & Decker Reports Q2 Earnings Beat

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidance
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!